Tenaya Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-35.4M | $-45.2M | $9.8M | $741.0K |
| FY2021 | $-60.8M | $-85.9M | $25.1M | $3.0M |
| FY2022 | $-104.4M | $-125.1M | $20.6M | $11.5M |
| FY2023 | $-102.1M | $-103.3M | $1.2M | $15.3M |
| FY2024 | $-90.5M | $-91.5M | $1.0M | $16.5M |
| FY2025 | $-68.3M | $-68.9M | $618.0K | $13.0M |